Cargando…
Initial testing of pegfilgrastim (Neulasta Onpro) on‐body injector in multiple radiological imaging environments
PURPOSE: An increasing number of implantable or external devices can impact whether patients can receive radiological imaging examinations. This study examines and tests the Neulasta (pegfilgrastim) Onpro on‐body injector in multiple imaging environments. METHODS: The injector was analyzed for four...
Autores principales: | Long, Zaiyang, Kurup, Anil Nicholas, Jensen, Nicole M., Hangiandreou, Nicholas J., Schueler, Beth A., Yu, Lifeng, Leng, Shuai, Wood, Christopher P., Felmlee, Joel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856482/ https://www.ncbi.nlm.nih.gov/pubmed/33395503 http://dx.doi.org/10.1002/acm2.13156 |
Ejemplares similares
-
Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2013) -
Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta(®) in healthy subjects: A randomized, double‐blind trial
por: Wynne, Chris, et al.
Publicado: (2020) -
A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®)
por: Wong, Gina, et al.
Publicado: (2020) -
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta(®)): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers
por: Moosavi, Shahrzad, et al.
Publicado: (2020) -
Impact of flexible noise control (FNC) image processing parameters on portable chest radiography
por: Kirby, Krystal M., et al.
Publicado: (2022)